Mark E. Dudley
7Patents
6h-index
9Co-inventors
56Inventor score
Filing activity: Apr 30, 1987 → Dec 6, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8034334B2 | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy | Human Necessities | 216 | Expired |
| US8383099B2 | Adoptive cell therapy with young T cells | Chemistry; Metallurgy | 159 | Active |
| US9074185B2 | Adoptive cell therapy with young T cells | Chemistry; Metallurgy | 114 | Active |
| US8287857B2 | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy | Human Necessities | 76 | Active |
| US4881994A | Iron oxide catalyst propellant, and method for making same | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4854981A | Iron oxide catalyst and method for making same | Emerging Cross-Sectional Technologies | 6 | Expired |
| US11401503B2 | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.